Indivior

INDV

Market cap $4.2B

Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.

Investors target stocks that have been on a bullish run. Stocks like INDV, AUGO, ERO and OI are seeing price strength, and the momentum is likely to continue.

Total Net Revenue Expected in the Range of $1,125 million to $1,195 million Total SUBLOCADE ®  Net Revenue Expected to be in the Range of $905 million to $945 million Non-GAAP Operating Expenses Expected in the Range of $430 million to $450 million Adjusted EBITDA Expected in the Range of $535 million to $575 million RICHMOND, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (Nasdaq: INDV) (“Indivior PLC” or the “Company”) today announced its full-year 2026 financial guidance.

Oregon-based Stonepine Capital Management reduced its Indivior stake by 250,000 shares in the third quarter. The overall position value fell by about $2.75 million from the previous period.

RICHMOND, Va. , Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it will be added to the S&P SmallCap 600® index, effective today.

Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified. Post-hoc analyses indicated the 300-mg monthly maintenance dose performed significantly better than the 100-mg monthly dose in participants reporting high-frequency fentanyl use.

New York City-based Newtyn Management increased its stake in Indivior by nearly 1.6 million shares in the third quarter, resulting in a net position change of $62.8 million. The transaction represents a nearly 4.1% change in 13F reportable assets under management.

RICHMOND, Va. , Nov. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced the Company has concluded the legacy U.S. Department of Justice (DOJ) matter by paying in full the outstanding obligation of $295 million associated with the matter.

RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference: Piper Sandler 37th Annual Healthcare Conference – New York City, NY Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2 nd.

INDV, PRLB, LVS and OII top Zacks' efficiency screen with strong margins and solid earnings surprises.